About 1 result found for searched term "1835667-12-3" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M45386 | Rezivertinib | EGFR/HER2 |
| BPI-7711 | ||
| Rezivertinib is an orally effective, highly selective and irreversible third-generation EGFR tyrosine kinase inhibitor (TKI) with high potency against common activating EGFR and resistant T790M mutations.Rezivertinib exhibits excellent CNS penetration and antitumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
